Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep832 | Pituitary and Neuroendocrinology | ECE2023

An Atypical Presentation of Hypopituitrism

Minhas Raisa , Bashir Keefah , Mitchell Catherine , Ling Yong , Tarigopula Giridhar , Alansari Mustafa , Wernig Florian , Tomlinson James

A 48-year-old male presented with headache, cough and recurrent nose bleeds. Clinical examination showed saddle shape nose deformity. His past medical history included primary hypothyroidism diagnosed at the age of 10 years, was taking levothyroxine. His brother had a Rathke’s cleft cyst, surgically removed. His blood test were as follows: Sodium 125mmol/l, TSH 0.10mU/l, free T4 10.2pmol/l, freeT3 2.6pmol/l, cortisol < 28nmol/l, prolactin 240mU/l, FSH 1.8U/l, LH 0.3U/...

ea0070aep570 | Pituitary and Neuroendocrinology | ECE2020

Challenges in the management of pituitary involvement in granulomatosis with Polyangitis (GPA): 2 cases managed at Imperial college healthcare trust

Behary Preeshila , Mendoza Nigel , Meeran Karim , Gontsarova Anastasia , Martin Niamh , Ellis Spencer , Tomlinson James , Levy Jeremy , Mc Adoo Stephen , Wernig Florian

Granulomatosis with Polyangitis (GPA) typically affects the lungs, kidneys and ENT system. Pituitary involvement is extremely rare, affecting less than 1% of all cases. The most common pituitary manifestations are secondary hypogonadism and Diabetes Insipidus (DI).Corticosteroids and immunosuppressive agents represent mainstay of medical management. Treatment needs to be initiated promptly and individualised according to clinical response.Case 1: A 54-ye...

ea0065p254 | Metabolism and Obesity | SFEBES2019

St James’s Hospital intensive care unit insulin discharge policy – A quality improvement project

Quinn Mark , Courtney Ashling , Smyth Coilin-Collins , Healy Marie-Louise , Pazderska Agnieszka , O'Connor Enda

Background: Many patients require IV insulin during their critical illness. Maintenance of insulin in St James’s Hospital ICU is governed by a local protocol. At the time of ICU discharge, IV insulin therapy is often stopped. Transitioning from IV to subcutaneous insulin is often done with endocrinology input. If this is unavailable inappropriate insulin dosing may increase the risk of hypo-/hyperglycaemia.Aims: To reduce the number of episodes of h...

ea0025pl8biog | Clinical Endocrinology Trust Visiting Professor Lecture | SFEBES2011

Clinical Endocrinology Trust Visiting Professor Lecture

Fagin James A

James A Fagin, Memorial Sloan-Kettering Cancer Center, New York, USA. AbstractJames A. Fagin is Chief of the Endocrine Service and a Member of the Human Oncology and Pathogenesis Program at Memorial Sloan-Kettering Cancer Center in New York, and a Professor of Medicine at Weill Medical College of Cornell University. He was formerly the James Heady Professor of Medicine and Director of the Division of Endocrinology and...

ea0031p332 | Steroids | SFEBES2013

Truncal fat distribution is associated with enhanced glucocorticoid excretion, increased 5α-reductase activity and higher insulin resistance independent of BMI in women with polycystic ovary syndrome

O'Reilly Michael , Hodson James , Crabtree Nicola , Hazlehurst Jon , Stewart Paul , Tomlinson Jeremy , Arlt Wiebke

Polycystic ovary syndrome (PCOS) is a clinical triad of anovulation, hyperandrogenism and insulin resistance. Patterns of fat distribution in PCOS may be associated with androgen activation, glucocorticoid metabolism and insulin resistance. Here we analysed the relationship between fat distribution, steroid metabolism and insulin resistance in women with PCOS.We compared results from 100 PCOS patients (Rotterdam criteria) with 80 sex- and BMI-matched con...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...

ea0041gp174 | Receptors &amp; Signalling | ECE2016

5β-reductase (AKR1D1) is a regulator of glucose homeostasis in human hepatocytes and development of model systems to define its role in metabolic liver disease

Nikolaos Nikolaou , Dunford James , Green Charlotte , Lee Wenhwa , Lim Reina , Gathercole Laura , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. 5β-reductase (AKR1D1) is predominantly expressed in the liver and is a crucial regulator of steroid hormone clearance as well as bile acid synthesis. Its role in pathogenesis of metaboli...

ea0038p396 | Steroids | SFEBES2015

Model systems to define the role of AKR1D1 in metabolic liver disease

Nikolaou Nikolaos , Gathercole Laura , Dunford James , Lee Wenhwa , Lim Reina , McKeating Jane , Oppermann Udo , Hodson Leanne , Tomlinson Jeremy

Non-alcoholic fatty liver disease is the hepatic manifestation of the global epidemic of metabolic disease. It is tightly associated with obesity and type 2 diabetes, yet the precise mechanisms that drive its aetiology are not fully defined. Steroid hormones, including glucocorticoids and sex steroids, regulate metabolic phenotype, and in addition, bile acids have recently been identified as potent metabolic regulators. AKR1D1 (5β-reductase), is predominantly expressed in...

ea0049ep798 | Neuroendocrinology | ECE2017

Dissecting the androgen excess phenotype of women with idiopathic intracranial hypertension

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Abstract: Idiopathic intracranial hypertension (IIH) is a devastating neurological condition, with elevated intracranial pressure of unknown aetiology. IIH is largely a disease of obese females of reproductive age. The clinical phenotype of IIH overlaps with polycystic ovary syndrome (PCOS), with prevalent obesity, hyperandrogenism and anovulation. In this study, we aimed to delineate the androgen excess phenotype of IIH women compared to those with PCOS and simple obesity. Wo...